Olema Oncology is a cancer medicines company focused on developing innovative treatments for breast cancer and other malignancies. Led by palazestrant (OP-1250), a complete estrogen receptor antagonist, and OP-3136, a KAT6 pathway inhibitor, the company aims to create more effective therapies that improve patient outcomes. Olema's team is dedicated to its mission of developing better medicines with clarity and intention.
Olema Oncology is seeking a Senior Director of Clinical Business Operations to support clinical trials and contract management. The role involves overseeing vendor relationships, managing RFPs, negotiating contracts, and ensuring regulatory compliance. The ideal candidate will have extensive experience in clinical research and a strong understanding of the clinical contracting process.
Olema Oncology is a cancer medicines company focused on developing innovative treatments for breast cancer and other malignancies. Led by palazestrant (OP-1250), a complete estrogen receptor antagonist, and OP-3136, a KAT6 pathway inhibitor, the company aims to create more effective therapies that improve patient outcomes. Olema's team is dedicated to its mission of developing better medicines with clarity and intention.
Revolution Medicines